Denmark
Intelligence de marché des dispositifs médicaux pour Denmark. Changements réglementaires, concurrents et tendances d'achats.
Signaux récents
A study investigates the effectiveness of sequential compression devices in stabilizing hemodynamics during shoulder surgery.
A study on DV3395's safety and performance in healthy adults was completed, using X-ray for monitoring.
AMS Denmark ApS has registered with the FDA under product code MQL, listing one medical device.
A completed study validated a non-invasive glucose measurement device's performance in hypoglycemia for Type 1 diabetes.
Study completed on biological markers predicting exercise capacity in CF-LVAD patients.
The SOMNOtouch NIBP device is validated for 24-hour ambulatory blood pressure measurement in a clinical study.
The CHEMPAQ XBC device enables at-home hematological monitoring for clozapine, enhancing treatment adherence.
A trial comparing AuraGain and I-gel for bronchoscopic intubation has been completed.
The pilot trial for the Hyposafe hypoglycaemia alarm device has been completed, demonstrating its safety and performance.
A study evaluated the treatment of humeral fractures using the Winsta PH device, sponsored by the University of Aarhus.
A completed study assessed a new ostomy device's performance in ileostomy patients using a measuring device.
Natus Medical Denmark ApS has registered with the FDA under product code LBI, listing one medical device.
The study evaluates the echoclip device's effectiveness in visualizing coronary anastomoses during bypass surgery.
A study investigates the accuracy of continuous glucose monitoring versus standard blood glucose measurements in hospitalized diabetes patients.
The CLOSE-UP III Trial compares MynxGrip to manual compression for vascular closure after femoral access angiography.
A completed study examined how haptic devices affect proficiency and skill retention in laparoscopic simulators.
A completed trial compared blood levels of semaglutide using two injection devices, PDS290 and DV3372.
The pilot study evaluating the Hyposafe hypoglycaemia alarm device has been terminated.
Medimaps Group and Radiobotics merge to enhance AI-driven musculoskeletal imaging solutions globally.
Novo Nordisk aims to leverage consumer insights to enhance its US market strategy for Wegovy and Ozempic.